Cargando…

Editorial: The role of immunophenotype in tumor immunotherapy response

Detalles Bibliográficos
Autores principales:	Qin, Yujuan, Song, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311080/ https://www.ncbi.nlm.nih.gov/pubmed/37396044 http://dx.doi.org/10.3389/fgene.2023.1222064

Ejemplares similares

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Editorial: Tumor microenvironment immunophenotypes and disease progression
por: Monteiro, Ana Carolina, et al.
Publicado: (2023)

Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response
por: Li, Xiang, et al.
Publicado: (2022)

Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
por: Offin, Michael, et al.
Publicado: (2019)

Identification of Immune-Related Risk Characteristics and Prognostic Value of Immunophenotyping in TNBC
por: Yi, Jiarong, et al.
Publicado: (2021)

Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer
por: Zhang, Hongxian, et al.
Publicado: (2021)

Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma
por: Zhou, Wolong, et al.
Publicado: (2023)

Editorial: Genomics of immunoregulation and inflammatory responses in the tumor microenvironment
por: Zhao, Lan, et al.
Publicado: (2023)

Editorial: Combinatory Approaches of Epigenetic Regulators in T Cell-Based Immunotherapy
por: Zhou, Jingying
Publicado: (2022)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

Establishment and Application of a Prognostic Risk Score Model Based on Characteristics of Different Immunophenotypes for Lung Adenocarcinoma
por: Gao, Hong, et al.
Publicado: (2022)

Diffuse large B-cell lymphoma with continuously elevated immunoglobulin M following treatment: a case report with pathologic, immunophenotypic, and molecular analyses
por: Xiao, Fei, et al.
Publicado: (2023)

Ovarian Carcinosarcoma and Response to Immunotherapy
por: Daniyal, Muhammad, et al.
Publicado: (2023)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022)

The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer
por: Jiang, Xuefei, et al.
Publicado: (2022)

Editorial: The functional role of non-coding RNAs in tumor microenvironment and metastasis of genitourinary tumor and its potential application as tumor molecular biomarkers
por: Zhou, Zhongbao, et al.
Publicado: (2023)

PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy
por: Wu, Cen, et al.
Publicado: (2022)

Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature
por: Hu, Chuling, et al.
Publicado: (2022)

Biological characteristics of γδT cells and application in tumor immunotherapy
por: Zhu, Renhong, et al.
Publicado: (2023)

Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia
por: Duong, Lelinh, et al.
Publicado: (2018)

Editorial: Multi-omics analysis in tumor microenvironment and tumor heterogeneity
por: Shi, Yuxin, et al.
Publicado: (2023)

CMTM7 recognizes an immune-hot tumor microenvironment and predicts therapeutic response of immunotherapy in breast cancer well
por: Jiang, Xingyu, et al.
Publicado: (2022)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023)

Editorial: The role of entropy and information in evolution
por: Cushman, Samuel A.
Publicado: (2023)

Editorial: Role of RNA Modification in Disease
por: Buratti, Emanuele, et al.
Publicado: (2019)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

Comprehensive Analysis of Tumor Immune Microenvironment Characteristics for the Prognostic Prediction and Immunotherapy of Oral Squamous Cell Carcinoma
por: Zhao, Yijie, et al.
Publicado: (2022)

Editorial: Recent advances in genetic and proteomic biomarkers involved in the early detection of solid tumors
por: Li, Jitian, et al.
Publicado: (2023)

Editorial: Applications of RNA-seq in cancer and tumor research
por: Lang, Jidong, et al.
Publicado: (2023)

Circulating Tumor DNA Response and Minimal Residual Disease Assessment in DNA Polymerase Epsilon-Mutated Colorectal Cancer Undergoing Immunotherapy
por: Lutfi, Areeb, et al.
Publicado: (2023)

Role of Immunophenotypes in Carcinoma Breast
por: Shukla, Samarth, et al.
Publicado: (2018)

Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
por: Xu, Ziqian, et al.
Publicado: (2021)

Editorial: Role of RNA in Molecular Diagnostics of Cancer
por: Cho, William C. S., et al.
Publicado: (2020)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Wang, Helin, et al.
Publicado: (2022)

Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
por: Wang, Jia‐Bin, et al.
Publicado: (2023)

Editorial: Mutational signatures and immune response in cancer
por: Georgakopoulos-Soares, Ilias, et al.
Publicado: (2023)

A novel immune signature predicts immunotherapy responsiveness and reveals the landscape of the tumor immune microenvironment in head and neck squamous cell carcinoma
por: Wang, Qiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fk297lp51os5vg2f42ood4cd5g